Store
Worldwide Market for Hematology, 2026–2031
Publication Date: October 13, 2026
Tags: Blood, Diagnostics, Diagnostics Market Research, Hematology, In Vitro Diagnostics (IVD), IVD, Labs, POC, Point of Care, Point-of-Care (POC) Diagnostics, Point-of-Care (POC) Testing
Pages: 75
SKU: 26-051KA
The complete blood count is one of the most frequently ordered tests in medicine, and the instruments that run it are changing faster than the test itself. Hematology is a mature IVD segment, but competition no longer centers only on cell counting. Vendors now compete on automation, digital morphology, AI-assisted cell classification and the ability to put full CBC testing outside the central laboratory. Worldwide Market for Hematology, 2026–2031 from Kalorama Information looks at where that shift creates revenue and which suppliers are positioned to capture it.
What the Report Covers
The report sizes and forecasts the global hematology testing market across two segments: laboratory-based hematology and decentralized (point-of-care) hematology. The laboratory segment is examined by vendor share, reagent sales by test type, and region. The decentralized segment is split into lab-style compact instruments and handheld devices. It also separates hemoglobin and hematocrit testing from other routine hematology performed near the patient.
Regional analysis covers North America, Europe, Asia Pacific and the Rest of World. For each region, the report breaks out laboratory and point-of-care sales.
Technology and Market Trends
The report examines the forces shaping purchasing decisions, including:
- Digital morphology. The report covers the move from cell-gallery systems to full-field smear imaging, and the role of remote review in laboratory networks facing staffing shortages.
- AI in hematology. Applications include flagging, specimen triage, autoverification and longitudinal result analysis. The report also covers the regulatory and validation limits on how quickly this software can change.
- Decentralized testing. Cartridge-based and compact analyzers are taking CBC testing into oncology clinics, urgent care and physician offices. The report explains the practical difference between CLIA-waived and moderate-complexity systems.
- Combined testing. Some analyzers pair the CBC with CRP, ESR or HbA1c measurement from a single specimen.
Competitive Analysis
The report provides vendor market shares for both laboratory and point-of-care segments, company revenue estimates, and a tiered view of the supplier base. Leading suppliers are profiled, including Sysmex, Beckman Coulter/Danaher, Mindray, Roche, Siemens Healthineers, Abbott, HORIBA and Nihon Kohden.
A dedicated section on China examines centralized procurement, payment reform, import substitution and the rise of domestic manufacturers. FDA registration and CLIA categorization trends are also analyzed. Product tables cover recent analyzer introductions, digital morphology systems, quality control products and point-of-care platforms.
Scope and Methodology
Market estimates are presented in U.S. dollars for 2026, with forecasts through 2031. Values are based on factory sales to the end user rather than retail pricing or reimbursement. The market includes analyzers, instruments and reagents sold for commercial laboratory and hospital use, some research-use products used in clinical laboratories, and over-the-counter products. Test services are excluded.
The analysis draws on company, government and medical organization reports, supported by literature searches and interviews with industry professionals and IVD experts.
Who Should Read This Report
This report is written for diagnostics manufacturers, component and reagent suppliers, investors, business development teams and strategic planners. It is especially relevant to anyone evaluating opportunities in laboratory automation, digital morphology or near-patient hematology.
Chapter 1: Executive Summary
About Kalorama Information
Hematology Overview
Market Overview
- Table 1-1: Global Hematology Testing Market, by Product Segment, 2026-2031 Est. (US$ millions) [Decentralized (POC) Hematology, Laboratory-based Hematology]
Scope and Methodology
Chapter 2: Overview of Hematology and Trends
Introduction
- Figure 2-1: Hematology Analyzer Distribution of Sales by Menu Capability, 2026 Est. (%)
Digital Image Analysis
- Table 2-1: CellaVision Market Share Data by Hematology Vendor, 2026 Est. (%)
- Table 2-2: Selected Hematology Image Analysis Innovations
Digital Evolution
Artificial Intelligence in IVD Hematology
Quality Control Measurement Programs
- Table 2-3: Selected Hematology Quality Control Products, 2026
Chapter 3: Laboratory-based Hematology Testing
Overview
Product Overview
- Table 3-1: Selected Hematology Innovations, 2026
- Table 3-2: Lab-Based Hematology Test and Instrument Market Share, by Vendor, 2026 Est. (%)
Market Summary
- Table 3-3: Global Laboratory-based Hematology Test and Instrument Market, 2026 and 2031 (US$ millions)
- Figure 3-1: Lab-based Hematology Sales by Reagent, 2026 Est. (%)
Regional Laboratory-based Hematology Test and Instrument Market
- Table 3-4: Global Laboratory-based Hematology Test and Instrument Market, by Region, 2026 Est. (%)
- Figure 3-2: Laboratory-based Hematology Test and Instrument Market, Regional Analysis, 2026 Est. (%)
Chapter 4: Decentralized Hematology Testing
Overview
Hemoglobin/Hematocrit at the POC
- Table 4-1: POC Hematology Distribution by Specialty (Hematocrit/Hemoglobin vs. Other Routine Hematology), 2026 (%)
- Table 4-2: Selected Hematocrit and Hemoglobin POC Systems, 2026
- Table 4-3: Selected POC Hematology Analyzer Systems, 2026
- Table 4-4: POC-Based Hematology Test and Instrument Market Share by Vendor, 2026 Est. (%)
Decentralized (POC) Market Summary
- Table 4-5: Decentralized Hematology Test and Instrument Market, 2026 and 2031 Est. (US$ millions)
Regional Decentralized Hematology Test and Instrument Market
- Table 4-6: Global Decentralized Hematology Test and Instrument Market, by Region, 2026 Est. (%)
- Figure 4-1: Decentralized Hematology Test and Instrument Market, Regional Analysis, 2026 (%)
Chapter 5: Market Analysis & Leading Suppliers
Summary
- Figure 5-1: Laboratory Hematology Analyzer CLIA Categorizations by Year, 2000–2026 YTD
- Figure 5-2: FDA Registration Distribution by Company for Hematology Analyzers/Instruments (%)
- Table 5-1: Hematology Market Revenue Distribution, by Product Type, 2026 Est. (%) [Analyzers, Instruments and Reagents]
- Figure 5-3: Global Hematology Market Value, by Segment, 2026 Est. (US$ millions) [Laboratory-based and Decentralized (POC)]
- Table 5-2: Global Hematology (Laboratory-based and POC) Sales Distribution, by Region, 2026 (%)
- Figure 5-4: Global Hematology Market, by Testing Platform (Laboratory-based, POC) and Region, 2026 (US$ millions)
- Figure 5-5: North America Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
- Figure 5-6: North America Hematology Market Share, Laboratory-Based and POC Segments, 2026 (%)
- Figure 5-7: Europe Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
- Figure 5-8: Europe Hematology Market Share, Laboratory-Based vs. POC, 2026 (%)
- Figure 5-9: Asia Pacific Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
- Figure 5-10: Asia Pacific Hematology Market Share, Laboratory-Based vs. POC, 2026 (%)
- Figure 5-11: Rest of World Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
- Figure 5-12: Rest of World Hematology Market Share, Laboratory-Based vs. POC, 2026 (%)
Leading Suppliers
- Table 5-3: Hematology, Company Revenues (laboratory and POC), 2026 Est. (US$ millions)
- Table 5-4: Hematology Vendors (Laboratory, POC), 2026
China and IVD Hematology
The Commercial Outlook for Hematology Tests
Related products
In Vitro Diagnostic (IVD) Test Procedure Volumes, 8th Edition
September 8, 2026
The world runs on roughly 150 billion diagnostic tests a year—and that number is climbing faster than the revenue behind it. IVD Test Procedure Volumes, 8th Edition quantifies that divergence with precision, tracking global procedure volumes segment by segment and region by region as the diagnostics industry completes its transition out of the pandemic era.…
Price range: $7,000.00 through $10,000.00
30-Country IVD Market Atlas, 2026 – July Update
July 20, 2026
Kalorama’s 30-Country IVD Market Atlas sizes and forecasts the in vitro diagnostics market across 30 key countries and 18 segments, with five-year projections through 2030 and country-level revenue data updated through June 2026.
Price range: $5,600.00 through $8,000.00
IVD Test Procedure Volumes, 7th Edition (2025-2030)
October 17, 2025
The global in vitro diagnostics (IVD) market continues to expand in 2025, driven by powerful innovations in next-generation sequencing (NGS), microfluidics, and precision medicine that are transforming diagnostics into a more personalized, patient-centric field. IVD Test Procedure Volumes, 7th Edition (2025-2030) provides a comprehensive, data-driven analysis of global test volume trends, serving as a critical…
Price range: $7,000.00 through $10,000.00
